Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2020 and to consider recommendation of dividend (if any).